Eysz, Inc.

Berkeley, CA

UEI
NRJKJM6EB163
CAGE
84PC5
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2838 Benvenue Ave, Berkeley, CA 94705, USA
Website
eyszlab.com
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Eysz, Inc. is a woman-owned small business based in Berkeley, California, that specializes in developing mobile health technology platforms for neurological applications. The company is registered with the federal government under UEI NRJKJM6EB163 and maintains active SAM.gov registration through August 1, 2026. Eysz, Inc. provides federal grant funding recipients with innovative software and algorithmic solutions designed to improve diagnosis and monitoring of neurological conditions, particularly epilepsy. The company's core expertise lies in leveraging advanced data collection and analysis methods, including video recording, eye-tracking technology, and biometric measurements, to create non-invasive diagnostic tools that address significant gaps in current clinical practice.

Eysz, Inc. has received four federal grant awards totaling approximately $1.054 million across multiple funding agencies and programs. Most recently, in September 2025, the company received a $542,373 Fast Track Small Business Innovation Research (SBIR) Project Grant from the National Institute of Nursing Research under the Nursing Research program (CFDA 93.361) to develop and validate a home-based version of the EYSZ HV Recorder mobile health platform for detecting childhood absence epilepsy through hyperventilation-induced seizure provocation and facial video analysis, with completion targeted for July 31, 2026. In September 2023, Eysz received an SBIR Project Grant from the National Institute of Neurological Disorders and Stroke focused on developing mobile health application algorithms that combine guided hyperventilation with eye-movement recordings to diagnose and monitor childhood absence epilepsy remotely. Additionally, the company received an SBIR Phase II Cooperative Agreement from the National Science Foundation in June 2023 to assess comorbidities in epilepsy using eye-movement recordings and wearable device technology to detect neurocognitive symptoms and anti-epilepsy drug side effects. The company's earliest federal grant award was a Phase I SBIR Project Grant of $256,000 from the National Science Foundation's Division of Industrial Innovation in December 2021, which supported identification of interictal features of epilepsy through oculometric data analysis in naturalistic settings. Throughout all awards, Eysz has operated as a prime awardee with no identified subcontractors, maintaining full responsibility for the research, development, and validation of its mobile health technologies.

Quick answers

Is Eysz, Inc. registered in SAM.gov?

Yes. Eysz, Inc.'s SAM.gov registration is active through June 2, 2027.

What is Eysz, Inc.'s CAGE code?

Eysz, Inc.'s CAGE code is 84PC5, and its Unique Entity ID (UEI) is NRJKJM6EB163.

What is Eysz, Inc.'s most recent federal award?

Eysz, Inc.'s most recent federal grant award is Detecting absence seizures using hyperventilation in a home environment (R44NR021881), from National Institute of Nursing Research (NIH), on September 26, 2025.

On GovTribe

See Eysz, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe